Brown Brothers Harriman & Co. Has $907,000 Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Brown Brothers Harriman & Co. raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,022 shares of the company’s stock after acquiring an additional 116 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in HCA Healthcare were worth $907,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at about $36,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth approximately $39,000. Activest Wealth Management raised its position in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $342.25 on Monday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company’s 50-day moving average price is $324.53 and its two-hundred day moving average price is $340.92. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $84.26 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business posted $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Bank of America lowered their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Barclays decreased their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.